Nengwei Zhang

机构：Peking University, Peking University International Hospital, Beijing Shijitan Hospital · ORCID：0000-0002-9412-2652

发表论文 156 篇 · 总被引 1597 次 · h-index 19

代表论文

• A global survey on the use of the international classification of diseases codes for metabolic dysfunction-associated fatty liver disease (2024 · Hepatology International · 被引 34)
• Cancer‐associated fibroblast‐derived MMP11 promotes tumor progression in pancreatic cancer (2024 · Cancer Science · 被引 27)
• Dopamine in the regulation of glucose and lipid metabolism: a narrative review (2024 · Obesity · 被引 14)
• Performance of MAST, FAST, and MEFIB in predicting metabolic dysfunction‐associated steatohepatitis (2024 · Journal of Gastroenterology and Hepatology · 被引 14)
• Clinical study on the necessity and feasibility of routine MRCP in patients with cholecystolithiasis before LC (2024 · BMC Gastroenterology · 被引 14)
• MSLN induced EMT, cancer stem cell traits and chemotherapy resistance of pancreatic cancer cells (2024 · Heliyon · 被引 12)